Çàðåãèñòðèðîâàòüñÿ

Ïîõîæèå òåìû

  1. Ïèñ÷èé ñïàçì
    îò Àííà Õëóä â ðàçäåëå Íåâðîëîã è íåéðîõèðóðã
    Îòâåòîâ: 16
    : 16.02.2023, 13:25
  2. ×ÅËÞÑÒÍÎÉ ÑÏÀÇÌ
    îò Tatyana_08 â ðàçäåëå Ìàíóàëüíûé òåðàïåâò
    Îòâåòîâ: 1
    : 21.03.2007, 18:46
  3. ×åëþñòíîé ñïàçì
    îò Simplicita â ðàçäåëå Ìàíóàëüíûé òåðàïåâò
    Îòâåòîâ: 1
    : 18.05.2006, 15:31
  4. Ñïàçì àêêîìîäàöèè
    îò Îëÿ-ëÿ â ðàçäåëå Çðåíèå, î÷êè, îôòàëüìîëîã
    Îòâåòîâ: 3
    : 18.06.2005, 18:14
  5. Ñïàçì
    îò 1234567 â ðàçäåëå Ïñèõîëîãèÿ è ïñèõîòåðàïèÿ, äåïðåññèè
    Îòâåòîâ: 3
    : 27.01.2005, 23:49
  1. Àííà Õëóä
    #1
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûå êîëëåãè. Âïåðâûå â ñâîåé ïðàêòèêå âñòðåòèë áîëüíîãî ñ ïèñ÷èì ñïàçìîì. Êðàòêî åãî èñòîðèÿ áîëåçíè: áîëåí ñ 1996 ãîäà. Íà ïðîòÿæåíèè ýòîãî ïåðèîäà ïåðèîäè÷åñêè âîçíèêàëè îáîñòðåíèÿ. Óëó÷øåíèå ïðèíîñèëà òîëüêî ðåôëåêñîòåðàïèÿ (ïðîâîäèëèñü êóðñû ëå÷åíèÿ 3-4-5 ðàç â ãîä).  íåâðîëîãè÷åñêîì ñòàòóñå – ïîëíàÿ íîðìà, çà èñêëþ÷åíèåì íåðåçêî âûðàæåííîãî áîëåçíåííîãî ñïàçìà ìûøö êèñòè è ïðåäïëå÷üÿ ïðè ïîïûòêå ïèñüìà. Áîëüíîé íàó÷èëñÿ ïèñàòü ëåâîé ðóêîé. Íà ïðîòÿæåíèè ïîñëåäíåãî ãîäà ñòàëè âîçíèêàòü òðóäíîñòè è ñ ëåâîé ðóêîé.

    Ïîäñêàæèòå, âîçìîæíî, åñòü íîâûå ìåòîäû ëå÷åíèÿ ýòîãî çàáîëåâàíèÿ. Çàðàíåå ñïàñèáî.

  2. Penka
    #2
    ×èòàòåëü Íåäóã.Ðó
    Îïèøèòå ïîäðîáíåå âîçðàñò áîëüíîãî, ïðîôåññèÿ, íà÷àëî áîëåçíè, òå÷åíèå, ãäå ëå÷èëñÿ, ñêîëüêî ðàç ëå÷èëñÿ, åñòü ëè äðóãèå ãèïåðêèíåçû è áûëè ëè ðàíåå, êàê ñàì áîëüíîé ðàññêàçûâàåò î ñâîåé áîëåçíè, êàêîâ ïñèõîëîãè÷åñêèé ïðîôèëü áîëüíîãî,áûëè ëè ïñèõîòðàâìèðóþùèå ñèòóàöèè ïåðåä ðàçâèòèåì áîëåçíè è â äàëüíåéøåì, ñåìåéíîå ïîëîæåíèå, íàñëåäñòâåííûå çàáîëåâàíèÿ â ñåìüå áîëüíîãî. Îïèøèòå ñîñòîÿíèå êèñòè íà ñåãîäíÿøíèé äåíü, ïîëüçóåòñÿ ëè îí åé äëÿ äðóãèõ öåëåé, êðîìå ïèñüìà- çàñòåãèâàíèå ïóãîâèö, ïðè ïðèåìå ïèùè è ò.ï. Åñòü ëè êîððèãèðóþùèå æåñòû? Êàêèå èíñòðóìåíòàëüíûå îáñëåäîâàíèÿ ïðîâîäèëèñü?

  3. Èðèíà Àíàòîëüåâ
    #3
    ×èòàòåëü Íåäóã.Ðó
    Çäðàâñòâóéòå



    Òî ÷òî â ýòîì ñëó÷àå ðåôëåêñîòåðàïèÿ - êñòàòè, êàêîé âèä? - ïîìîãëà - ïî÷òè íàâåðíÿêà óêàçûâàåò íà ñòðåññîãåííîñòü äàííîãî ñëó÷àÿ. Ðåêîìåíäóþ ïðîäîëæèòü êóðñ ðåôëåêñîòåðàïèè ñ îäíîâðåìåííîé ïñèõîòåðàïèåé - èç ëè÷íîãî îïûòà ìîãó äîáàâèòü, ÷òî ðåôëåêñîòåðàïèþ è ïñèõîòåðàïåâòè÷åñêèå ñåàíñû ñëåäóåò ïî âîçìîæíîñòè âûïîëíÿòü îäèí çà äðóãèì â êîðîòêèé ïðîìåæóòîê âðåìåíè - ýôôåêòèâíîñòü ïñèõîòåðàïèè çíà÷èòåëüíî ïîâûøàåòñÿ.



    Âñåãî Âàì íàèëó÷øåãî

  4. ëèêà
    #4
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé È.Í.Åôèìîâ. Äàþ îòâåòû íà Âàøè âîïðîñû. Âîçðàñò áîëüíîãî 38 ëåò. Áîëååò ñ 30 ëåò. Ïðîôôåñèÿ – çàíèìàåò ðóêîâîäÿùóþ äîëæíîñòü ñòðîèòåëüíîé îðãàíèçàöèè. Íà÷àëî áîëåçíè: îòìåòèë íåêîòîðûå òðóäíîñòè ïðè ïîïûòêå ïèñüìà â 1996 ãîäó, òî åñòü ïèñàòü ìîã, íî ðóêà áûñòðî óñòàâàëà, áîëåçíåííûõ ñïàçìîâ íå áûëî. Ïîñòåïåííî îòìåòèë, ÷òî ïèñàòü ñòàíîâèòñÿ ñëîæíåå, ðóêà áûñòðî óñòàâàëà. Îäíîâðåìåííî îòìåòèë, ÷òî ñëàáîñòü ïðàâîé ðóêè âîçíèêàëà íå òîëüêî ïðè ïèñüìå, íî è â áûòó (ïðè âûïîëíåíèè ôèçè÷åñêîé ðàáîòû ðóêà áûñòðî óñòàâàëà). Áîëåçíåííûå ñïàçìû ìûøö êèñòè âïåðâûå âîçíèêëè â 2000 ãîäó. Ïèñàòü íå ìîã âîîáùå (âåðíåå ìîã, íî òîëüêî åñëè êèñòü íå áûëà ôèêñèðîâàíà ê ñòîëó – òî åñòü êèñòü è ïðåäïëå÷üå áûëè â âîçäóõå. Íàó÷èëñÿ ïèñàòü ëåâîé ðóêîé.  òàêîì ïîëîæåíèè ïèøåò è òåïåðü (õîòü ïîëó÷àåòñÿ ìåäëåííî è íå î÷åíü ðàçáîð÷èâî).  2004 ãîäó âîçíèêëè òðóäíîñòè è ñ ëåâîé ðóêîé. Ñïàçìîâ åù¸ íåò, íî ïèñàòü òðóäíåå, ÷åì ðàíüøå, ðóêà áûñòðî óñòà¸ò. Áîëüíîé èñïîëüçóåòñÿ ðóêó äëÿ âûïîëíåíèÿ äðóãèõ öåëåé.

    Íà ðåíòãåíîãðàììå øåéíîãî îòäåëà – îñòåîõîíäðîç. Íà ÅÌÃ: áëîê ïðîâåäåíèÿ F-âîëí, ÷òî ðàñöåíèâàåòñÿ êàê ðàçäðàæåíèå ïåðåäíèõ êîðåøêîâ íà óðîâíå Ñ6-Ò1 ñïðàâà. Íà ãëîáàëüíîé ÅÍÌà äèñòàëüíîé ãðóïïû ìûøö âåðõíèõ êîíå÷íîñòåé ðåãèñòðèðóåòñÿ 2-îé òèï (çà Þñåâè÷) èíòåðôåðåíòíîé êðèâîé, «íåâðàëüíûé». ÅÅà áåç îñîáåííîñòåé. Åêñòðàêðàíèàëüíàÿ äîïëåðîãðàôèÿ – óòðóäíåííûé âåíîçíûé îòòîê â âåðòåáðî-áàçèëÿðíîì áàññåéíå ñ îáåèõ ñòîðîí.

    Ïî ìíåíèþ áîëüíîãî ê íà÷àëó ðàçâèòèÿ áîëåçíè ïðèâåëè ìíîãî÷èñëåííûå ñòðåññîâûå ñèòóàöèè, êîòîðûå âîçíèêàëè íà ðàáîòå (óâîëüíåíèÿ – òðèæäû, ñ ïîñëåäóþùèìè âîññòàíîâëåíèÿìè, è äðóãèå èíöèäåíòû ïîìåëü÷å).  äàëüíåéøåì âîçíèêàëè ñëîæíîñòè íà ðàáîòå èç-çà áîëåçíè. Ñåìåéíàÿ æèçíü áîëüíîãî áåç îñîáûõ ïðîáëåì. Ñàì áîëüíîé ñïîêîéíûé, ñäåðæàííûé.

    Íàñ÷åò ëå÷åíèÿ: èñïðîáîâàë êëàññè÷åñêóþ è íåòðàäèöèîííóþ òåðàïèþ. Îáúåçäèë âñåâîçìîæíûå ëå÷åáíûå ó÷ðåæäåíèÿ Óêðàèíû.  ðåçóëüòàòå îñòàíîâèëñÿ íà èãëîðåôëåêñîòåðàïèè, êîòîðàÿ äàâàëà äîâîëüíî íå ïëîõîé ðåçóëüòàò (òàêèå êóðñû ïðîõîäèë îò 2 äî 4 íà ãîä.

    Äðóãèõ ãèïåðêèíåçîâ íåò è ðàíüøå íå áûëî. Íàñëåäñòâåííûõ çàáîëåâàíèé â ñåìüå áîëüíîãî íåò.

    Ñ óâàæåíèåì, Ðîñòèñëàâ

  5. vivere
    #5
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Ñåðãåé Àëåêñàíäðîâè÷, ïèñ÷èé ñïàçì (Writer"s crampi) ýòî íå ñèíäðîì, à ðàçíîâèäíîñòü ôîêàëüíîé äèñòîíèè. Òî÷íûå ïðè÷èíû íåèçâåñòíû, íî ïðåäïîëàãàåòñÿ, ÷òî çàáîëåâàíèå ñâÿçàíî ñ äèñôóíêöèåé áàçàëüíûõ ãàíãëèåâ è ïîâûøåíèåì àêòèâíîñòè íåéðîíîâ â ïðåìîòîðíûõ îáëàñòÿõ êîðû. Âñòðå÷àþòñÿ, íî ðåæå, òàêèå ïðè÷èíû ïèñ÷åãî ñïàçìà, êàê ãðûæà C6 äèñêà, èñïîëüçîâàíèå ëèòèÿ, îïóõîëè â îáëàñòè áàçàëüíûõ ãàíãëèåâ è øåéíîãî îòäåëà ñïèííîãî ìîçãà, àðòåðèîâåíîçíàÿ ìàëüôîðìàöèÿ, èíñóëüò. Òîãäà ïèñ÷èé ñïàçì áóäåò ñèìïòîìîì. Íî ÷àùå âñå æå âñòðå÷àåòñÿ èäèîïàòè÷åñêèé ïèñ÷èé ñïàçì. Òåì íå ìåíåå äèôäèàãíîñòèêà íåîáõîäèìà.  ëå÷åíèè èäèîïàòè÷åñêîãî ïèñ÷åãî ñïàçìà ñåé÷àñ íàèáîëåå ýôôåêòèâíûì ìåòîäîì ëå÷åíèÿ ñ÷èòàåòñÿ ïðèìåíåíèå èíúåêöèé áîòóëîòîêñèíà ( Áîòîêñ, Äèñïîðò) â ìûøöû ïðåäïëå÷üÿ è êèñòè ïîä êîíòðîëåì ýëåêòðîìèîãðàôèè.

    J Med Assoc Thai. 1991 May;74(5):239-47. Related Articles, Links



    Writer's cramp: the experience with botulinum toxin injections in 25 patients.



    Poungvarin N.



    Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.



    Twenty-five writer's cramp patients have been attending the Movement Disorder Clinic at the Division of Neurology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok during three years period (between January 1988 - January 1991). There were 17 male subjects and the male to female sex ratio was 2.125:1. The mean age of the patient was 36.80 (SD 10.21) years with the range of 18-60 years. The mean duration of illness of all patients was 5.88 (SD 7.14) years with the range of 1 to 30 years. Eighteen patients (72.0%) were classified as simple writer's cramp and seven patients (28.0%) were dystonic writer's cramp. The mean age of the patients of both groups was not different while the duration of illness in the dystonic group was statistically significantly longer than the simple group, i.e. 12.0 (SD 12.1) versus 3.9 (SD 3.1) years. Fourteen patients (56%) had associated pain during writing and 6 patients (24%) had hand tremor. All patients were right handed and had a history of various pharmacological treatments without any consistent benefit. They included muscle relaxants, tranquillisers, antiepileptic drugs, and betablockers. Fourteen patients from 17 available history records (82.4%) had been spending at least 4-10 hours writing each day. Twenty-one patients (84%) had botulinum toxin injections, 40-80 international mouse units were given in 2-4 divided doses over the overactive forearm muscles observed during writing without the electromyographic glidance. There was no loss to the follow-up. Fourteen of the 21 subjects (66.7%) showed definite improvement in hand writing, 4 patients (19.0%) improved minimally and 3 patients (14.3%) revealed no improvement. Arm pain in all 12 patients associated during writing was abolished after the injections. There were complications in 7 patients (33.3%) presented as transient finger drop (5 patients, 23.8%) and easily fatigued arm (2 patients, 9.5%). These preliminary results confirm that botulinum toxin injections is a successful treatment for many patients with writer's cramp without performing complex electromyographic recordings while the patients are writing. The constraints of this treatment are its high cost (i.e. 1 vial of 100 units costs 300 US dollars) and its benefit lasts for only 4-6 months.



    Wien Klin Wochenschr. 2001;113 Suppl 4:6-10. Related Articles, Links



    [Treatment of focal dystonia with botulinum toxin A]



    [Article in German]



    Sojer M, Wissel J, Muller J, Poewe W.



    Universitatsklinik fur Neurologie, Innsbruck, Osterreich.



    Local injections with Botulinum toxin A (BtxA) are safe and effective in the treatment of focal dystonia. In cervical dystonia and blepharospasm, BtxA injections have become the treatment of choice. However, good results have also been reported with oromandibular dystonia, spasmodic dysphonia and writer's cramp. In cervical dystonia, muscles for injection are selected by clinical presentation or in complex forms with EMG guidance. Several studies have shown that 500 units Dysport are safe and effective in the treatment of cervical dystonia. In blepharospasm, injections are performed in the periorbital part of the orbicularis oculi muscle with good results for 12-14 weeks. The most frequently employed starting dose is 120 units Dysport per eye, divided in three periorbital injection sites. In case of levator inhibition, the pretarsal part of the orbicularis oculi muscle should be injected in a lower dose. EMG guidance is not necessary. By contrast, BtxA treatment of spasmodic dysphonia and writer's cramp require EMG-guided injections in order to avoid side-effects. Dose recommendations for the various types of dystonia are given in the text. In up to 5% of patients with dystonia, the development of neutralising antibodies is reported following repetitive injections with BtxA. Patients with antibodies had a shorter interval between injections, more "boosters", a higher dose per 3-month interval, and a higher total dose injected. In case of neutralizing antibodies against the A toxin, the treatment with Botulinum toxin B (Neurobloc) is a possible alternative.



    À òàêæå åñòü îïûò ïðèìåíåíèÿ òðàíñêðàíèàëüíîé ìàãíèòíîé ñòèìóëÿöèè:



    Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp.



    Murase N, Rothwell JC, Kaji R, Urushihara R, Nakamura K, Murayama N, Igasaki T, Sakata-Igasaki M, Mima T, Ikeda A, Shibasaki H.



    Department of Neurology, Tokushima University School of Medicine, Tokushima, Japan.



    Writer's cramp, or focal hand dystonia, is characterized by involuntary coactivation of antagonist or unnecessary muscles while writing or performing other tasks. Although the mechanism underlying this muscle overactivation is unknown, recent studies of changes in cerebral blood flow during writing have demonstrated a reduction in the activation of the primary motor cortex (MC) and hyperactivity of parts of the frontal non-primary motor areas. Therefore, any measures that decrease the activities of non-primary motor areas such as the premotor cortex (PMC) and the supplementary motor area (SMA) might improve dystonic symptoms. To explore this possibility, we studied nine patients with writer's cramp and seven age-matched control subjects, using subthreshold low-frequency (0.2 Hz) repetitive transcranial magnetic stimulation (rTMS), which exerts an inhibitory action on the cortex. Previous studies have demonstrated shortened cortical silent periods in dystonia, suggesting deficient cortical inhibition in the MC. We compared the silent periods and computer-assisted ratings of handwriting before and after rTMS applied to the MC, SMA or PMC. We also used the sham coil for control runs. Stimulation of the PMC but not the MC significantly improved the rating of handwriting (mean tracking error from the target, P = 0.004; pen pressure, P = 0.01) and prolonged the silent period (P = 0.02) in the patient group. rTMS over the other sites or using a sham coil in the patient group or trials in the control group revealed no physiological or clinical changes. This increased susceptibility of the PMC in dystonia suggests that the lack of inhibition in the MC is secondary to the hyperactivity of PMC neurons. Inhibition of the PMC using rTMS could provide a therapeutic measure of writer's cramp.

  6. Lecter
    #6
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Èãîðü Íèêîëàåâè÷,



    ÿ ïîíÿë, ÷òî "ïèñ÷èé ñïàçì" - ýòî ñèíäðîì.

    Íå ìîãëè áû Âû â òàêîì ñëó÷àå ïðèâåñòè ñïèñîê çàáîëåâàíèÿ äëÿ äèô. äèàãíîñòèêè?

  7. Valdi
    #7
    ×èòàòåëü Íåäóã.Ðó
    ß äóìàþ íóæíî ïðîâåäåíèå äèôäèàãíîçà ñ ïñèõîãåííîé äèñòîíèåé, êîíñóëüòàöèÿ ãðàìîòíîãî ïñèõèàòðà,òåñòèðîâàíèå ïî ÌÈË (ìíîãîñòîðîííåå èññëåäîâàíèå ëè÷íîñòè), øêàëå äåïðåññèè è òðåâîãè. Ïñèõîãåííàÿ äèñòîíèÿ ÷àùå íà÷èíàåòñÿ ñ íîãè è ïðèìåðíî â ïîëîâèíå ñëó÷àåâ âïîñëåäñòâèè ïåðåõîäèò íà ðóêè, îäíàêî åñòü îïèñàíèå ïàöèåíòêè ( Æ-ë íåâðîïàò. è ïñèõèàòðèè, 1996, ¹3, ñ. 90-92) ó êîòîðîé â ïñèõîãåííîé ñèòóàöèè íà ôîíå ñìåíû ïðîôåññèîíàëüíîãî ñòåðåîòèïà

    (ñìåíà ôîðòåïèàíî íà îðãàí) ïîÿâèëèñü áîëåçíåííûå ìûøå÷íûå ñóäîðîãè, à çàòåì è êîíòðàêòóðû â êèñòÿõ. ×åðåç 8 ëåò ïðè ðàçðåøåíèè ïñõîãåííîé ñèòóàöèè äâèãàòåëüíûå ðàññòðîéñòâà ïîëíîñòüþ èñ÷åçëè. Òàêæå íàäî îòìåòèòü, ÷òî ðàñïðîñòðàíåííàÿ ðàíåå òî÷êà çðåíèÿ, ñîãëàñíî êîòîðîé ïñèõîãåííûå íåâðîëîãè÷åñêèå ñèìïòîìû, êàê ïðàâèëî, âñòðå÷àþòñÿ ó èñòåðè÷åñêèõ ëè÷íîñòåé îêàçàëàñü îøèáî÷íîé. Ïî äàííûì ëèòåðàòóðû, ó áîëüíûõ ñ ïñèõîãåííûìè íåâðîëîãè÷åñêèìè ðàññòðîéñòâàìè ïåðâîå ìåñòî çàíèìàåò äåïðåññèâíûé ñèíäðîì ( äî 38% ïàöèåíòîâ), à èñòåðè÷åñêèå ÷åðòû îáíàðóæèâàþòñÿ ëèøü ó 9% áîëüíûõ ( Æ-ë íåâðîïàò. è ïñèõèàòðèè, 1988, ¹6, ñ. 80-84. Äàëåå, ðàç åñòü èçìåíåíèÿ ïðè ÝÌà (ïðåäïîëîæèì, ÷òî äîêòîð äåëàâøèé îáñëåäîâàíèå äîñòàòî÷íîé êâàëèôèêàöèè), òî ÷òî ìåøàåò ñäåëàòü ÌÐÒ èëè åñëè íåò ÌÐÒ, ÊÒà øåéíîãî îòäåëà ïîçâîíî÷íèêà?

  8. terra
    #8
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Èãîðü Íèêîëàåâè÷.

    Ñïàñèáî Âàì çà îòâåò è ñîâåò. Ñðàçó îòâå÷ó íà Âàø âîïðîñ. Ïðîâåäåíèå ÌÐÒ – ýòî âîïðîñ âðåìåíè, òàê êàê â íàøåì ðåãèîíå î÷åðåäü íà ýòî îáñëåäîâàíèå ðàñïèñàíà íà 2 ìåñÿöà äà è îñîáîé ñðî÷íîñòè â åãî ïðîâåäåíèè íåòó (ïî ìíåíèþ áîëüíîãî).

    Ïðîñìîòðåâ âàø äèàëîã ñ Ñåðãååì Àëåêñàíäðîâè÷åì Ïëÿñóíîâûì ó ìåíÿ âîçíèêëî íåñêîëüêî âîïðîñîâ.

    Çà÷åì ïðîâîäèòü ÝÌà ïðè ïðèìåíåíèè Áîòîêñà: äëÿ êîíòðîëÿ ïðàâèëüíîñòè ââåäåíèÿ ïðåïàðàòà (â îïðåäåë¸ííûå ãðóïïû ìûøö) èëè åñòü êðèòåðèè, ïî êîòîðûì ìîæíî ñóäèòü îá ýôôåêòèâíîñòè èëè æå íåýôôåêòèâíîñòè ïðèìåíåíèÿ äàííîãî ïðåïàðàòà? Åñòü ëè êàêèå òî îñîáåííîñòè èëè óñëîâèÿ ïðîâåäåíèÿ äàííîãî îáñëåäîâàíèÿ ó òàêèõ áîëüíûõ, êàêîâà ÷àñòîòà ïðîâåäåíèÿ îáñëåäîâàíèÿ? Áóäóò ëè èçìåíåíèÿ èííåðâàöèè ìûøö èëè æå ñàìèõ ìûøö êàê ïîáî÷íîå ÿâëåíèå ïðèìåíåíèÿ ïðåïàðàòà?

    Ëèòåðàòóðà ðåêîìåíäóåò âåäåíèå ïðåïàðàòà â äîçå 50-300 ÅÄ (äëÿ ìûøö êîíå÷íîñòåé). Ïðè ýòîì èìååò çíà÷åíèå ñòåïåíü ðàçâåäåíèÿ ïðåïàðàòà, êîëè÷åñòâî òî÷åê ââåäåíèÿ, îáúåì ìûøö, ñòåïåíü ìûøå÷íîãî ñïàçìà, âûðàæåííîñòü áîëåâîãî ñèíäðîìà. Åñòü ëè êàêèå òî ðåêîìåíäóåìûå àëãîðèòìû (êðèòåðèè) áîëåå òî÷íîãî ðàñ÷¸òà äîçû ïðåïàðàòà êîíêðåòíî äëÿ êàæäîãî èíäèâèäóóìà, òàê êàê ïîäîáðàòü àäåêâàòíî äîçó ïðè ÷àñòîòå ââåäåíèÿ ðàç â 3-6 ìåñÿöåâ íåâîçìîæíî?

    Åñòü ëè îïûò ïðèìåíåíèÿ áîòóëîòîêñèíà äðóãèõ òèïîâ (B,F) â ñëó÷àå îáðàçîâàíèÿ àíòèòåë ê áîòóëîòîêñèíó òèïà À? Òàê æå â ëèòåðàòóðå óïîìèíàåòñÿ î ñïåöïîäãîòîâêå âðà÷åé äëÿ ðàáîòû ñ äàííûì ïðåïàðàòîì.  ÷¸ì îíà ñîñòîèò?

    Áóäåò ëè åôåêòèâåí äàííûé ïðåïàðàò ïðè ïñèõîãåííîé äèñòîíèè èëè òîðòèêîëëåñå, êîòîðàÿ ïðîÿâëÿåòñÿ íå êàê îòäåëüíàÿ íîçîëîãè÷åñêàÿ åäèíèöà, à êàê ñèìïòîì ïðè îñòðîì ðàññåÿííîì åíöåôàëèòå?

    Çàðàíåå ñïàñèáî.

    Ñ óâàæåíèåì Ðîñòèñëàâ.

  9. Zina Merz
    #9
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Ðîñòèñëàâ, îïûòà ïðèìåíåíèÿ áîòóëîòîêñèíà ê ñîæàëåíèþ íå èìåþ, â ñâîåé ðàáîòå ïðèõîäèëîñü íàáëþäàòü ïàöèåíòà ñî ñïàñòè÷åñêîé êðèâîøååé, êîòîðûé ðàáîòàë âîäèòåëåì àâòîáóñà, òðàäèöèîííîå ìåäèêàìåíòîçíîå ëå÷åíèå áûëî áåç ýôôåêòà, íåéðîõèðóðãè âûïîëíèëè äàæå ðàññå÷åíèå êèâàòåëüíîé ìûøöû, íî è ýòî íå ïîìîãëî íè÷óòü, à âîò ïîñëå òîãî, êàê áîëüíîé ñúåçäèë â Ìîñêâó ê Î.Ð. Îðëîâîé ( êëèíèêà íåâðîëîãèè ÌÌÀ èì Ñå÷åíîâà), ãäå áûë ëå÷åí ââåäåíèåì áîòóëîòîêñèíà, ñïàçì ìîæíî ñêàçàòü ïîëíîñòüþ èñ÷åç è áîëüíîé

    âåðíóëñÿ ê ñâîåé ïðåæíåé ðàáîòå. Íó íå ÷óäî ëè? ×åðåç 8 ìåñ. ñîáèðàëñÿ íà ïîâòîðíûé êóðñ. Ê ñîæàëåíèþ ïîòîì íàøè ïóòè ðàçîøëèñü. Òîãäà åùå (ëåò 5 íàçàä) îí ìíå ïðèâåç íåáîëüøóþ ìåòîäè÷êó, à ïîòîì ïîÿâèëèñü ïóáëèêàöèè è â æóðíàëàõ, â ÷àñòíîñòè íåñêîëüêî ñòàòåé áûëî â æóðíàëå " Ëå÷åíèå íåðâíûõ áîëåçíåé" ïîä. ðåä. Âåéíà çà 2001 ãîä. Òà âîò ïèøóò, ÷òî âðà÷ ïðîâîäÿùèé èíúåêöèè áîòîêñà äîëæåí ïðîéòè ñîîòâåòñòâóþùåå îáó÷åíèå, ÷òîáû õîðîøî çíàòü àíàòîìèþ ìûøö è îâëàäåòü íàâûêàìè ââåäåíèÿ èãëû â íóæíûå ìûøöû, à òàêæå èìåòü ðàçðåøåíèå îò ôèðìû ïðîèçâîäÿùåé ïðåïàðàò. Öåíòðàëüíîãî äåéñòâèÿ ïðè â/ì ââåäåíèè áîòóëîòîêñèíà â òåðàïåâòè÷åñêèõ äîçàõ íå íàáëþäàåòñÿ. Ëå÷åíèå õîðîøî ïåðåíîñèòñÿ, ïîáî÷íûå ÿâëåíèÿ ðåäêè. Ìîãóò íàáëþäàòüñÿ ïðåõîäÿùàÿ ñëàáîñòü, ëèõîðàäêà è áîëü â ìåñòå èíúåêöèè. Êàê ïðàâèëî îíè íå òðåáóþò ëå÷åíèÿ è ïðîõîäÿò ñàìîñòîÿòåëüíî.  íàñòîÿùåå âðåìÿ èíúåêöèè áîòóëîòîêñèíà ïðèìåíÿþòñÿ â ëå÷åíèè ñïàñòè÷íîñòè ó äåòåé ñ ÄÖÏ, âçðîñëûõ ñ ðàçëè÷íûìè âèäàìè äèñòîíèé, áîëåâûìè ìûøå÷íûìè ñèíäðîìàìè, ãèïåðãèäðîçå. Îñîáåííîñòüþ ïðèìåíåíèÿ ïðåïàðàòà ïðè ïèñ÷åì ñïàçìå ÿâëÿåòñÿ áîëüøîå êîëè÷åñòâî ìûøö, ó÷àñòâóþùèõ â îáåñïå÷åíèè äâèæåíèé êèñòè è íåîáõîäèìîñòü ïðàâèëüíîé îöåíêè òåõ ìûøö, êîòîðûå íåïîñðåäñòâåííî ó÷àñòâóþò â ñïàçìå, äëÿ òîãî, ÷òîáû íå áûëî ñëàáîñòè â ðóêå ïðè èçáûòî÷íîì ââåäåíèè áîòóëîòîêñèíà. Ìîæíî ââîäèòü êîíå÷íî è áåç ìèîãðàôèè, îöåíèâàÿ ïàëüïàöèåé íàïðÿæåíèå ìûøö, íî ïðè èñïîëüçîâàíèè ìèîãðàôèè òî÷íîñòü ïîâûøàåòñÿ. Èñïîëüçóåòñÿ ïîðòàòèâíûé ìèîãðàô ñ ïîäêëþ÷åííîé îäíîðàçîâîé ïîëîé èãëîé ÷åðåç êîòîðóþ ââîäèòñÿ ïðåïàðàò. Äîçà ðàñ÷èòûâàåòñÿ èñõîäÿ èõ ìàññû è ðàçìåðà ìûøöû, â ñðåäíåì â íåáîëüøèå ìûøöû ââîäÿò ïî 25-75 åä, â áîëåå êðóïíûå ìûøöû 100 åä . Ñóììàðíàÿ äîçà íèêîãäà íå äîëæíà ïðåâûøàòü 1000 åä. Òåõíèêà èíúåêöèè äîñòàòî÷íî ïðîñòà: 500 åä Äèñïîðòà ( 1 ôëàêîí) ðàçâîäÿòñÿ â 2.5 ìë ôèçðàñòâîðà ( òàêèì îáðàçîì 0,5 ìë ðàñòâîðà ñîäåðæàò 100 åä Äèñïîðòà). Ðàñòâîð ïðåïàðàòà ââîäèòñÿ â ìûøöó â îäíó èëè äâå òî÷êè. Ïðè áûñòðîì ââåäåíèè íå òðåáóåòñÿ íèêàêîãî îáåçáîëèâàíèÿ.

    Ýôôåêòèâíîñòü ïðè ïèñ÷åì ñïàçìå 60-70%, äëèòåëüíîñòü ýôôåêòà îò 6-9 ìåñ. Ïðè íåîáõîäèìîñòè ïîâòîðÿþò êóðñ. Ïðè ñèìïòîìàòè÷åñêîì òîðòèêîëëèñå ýôôåêò òîæå äîëæåí áûòü. Ïðè ïñèõîãåííûõ âðÿä ëè, õîòÿ è íå èñêëþ÷àþ ïîëíîñòüþ.

    Ïî âñåì âîïðîñàì ïðèìåíåíèÿ áîòóëîòîêñèíà Âàì õîðîøî áû ñâÿçàòüñÿ ñ ä.ì.í. Îðëîâîé Î.Ð., ðàíåå îíà ðàáîòàëà â êëèíèêå íåðâíûõ áîëåçíåé ÌÌÀ èì. Ñå÷åíîâà. Ñåé÷àñ íå çíàþ. Ìîæåò áûòü ìîñêîâñêèå êîëëåãè ïîäñêàæóò?

  10. mr-who
    #10
    ×èòàòåëü Íåäóã.Ðó
    Ïî âñåì âîïðîñàì ïðèìåíåíèÿ áîòóëîòîêñèíà Âàì õîðîøî áû ñâÿçàòüñÿ ñ ä.ì.í. Îðëîâîé Î.Ð., ðàíåå îíà ðàáîòàëà â êëèíèêå íåðâíûõ áîëåçíåé ÌÌÀ èì. Ñå÷åíîâà. Ñåé÷àñ íå çíàþ. Ìîæåò áûòü ìîñêîâñêèå êîëëåãè ïîäñêàæóò?



    Ïðîô. Îðëîâà äî ñèõ ïîð ðàáîòàå â ÌÌÀ è çàíèìàåòñÿ ââåäåíèåì áîòîêñà.

    Ýôôåêò îò ââåäåíèÿ î÷åíü õîðîøèé. Îäíàêî ðàñïðîñòðàíåíèþ áîòîêñà â íåâðîëîãèè (íå â êîñìåòîëîãèè) ïðåïÿòñòâóåò îãðîìíàÿ öåíà (600-1000 äîëëàðîâ â çàâèñèìîñòè îò îáúåìà èñïîëüçóåìîãî ïðåïàðàòà) è êðàòêîñòðî÷íîñòü äåéñòâèÿ (÷åðåç 4-6 ìåñÿöåâ ýôôåêò ñíèæàåòñÿ, à ÷åðåç 7-8 ïðåêðàùàåòñÿ).

     ñâÿçè ñ ýòèì â Ìîñêâå ïðàêòè÷åñêè íèêòî àêòèâíî â íåâðîëîãèè èì íå çàíèìàåòñÿ. Ñëèøêîì ìàëî áîëüíûõ ñ òàêèìè äåíüãàìè. Õîòÿ êóðñû â ÌÌÀ ïðîéòè ìîæíî... Îäíà íåäåëÿ è ñåðòèôèêàò â êàðìàíå ñ âîçìîæíîñòüþ ïîêóïàòü ïðåïàðàò äëÿ ñâîèõ áîëüíûõ.



    Ëåæàë ó ìåíÿ â ïàëàòå ìàëü÷èê ñî ñïàñòè÷åñêîé êðèâîøååé (êîãäà â îðäèàòóðå ó÷èëñÿ). Òàê èç-çà îòñóòñâèÿ äåíåã òàê è îñòàëñÿ èíâàëèäîì, õîòÿ è ê Îðëîâîé åçäèë è â Áîòêèíñêóþ â öåíòð ýêñòðàïèðàìèäíîé ïàòîëîãèè...

  11. Ëåêñóñ
    #11
    ×èòàòåëü Íåäóã.Ðó
    Åñëè ïðè÷èíà ïñèõîãåííàÿ, òî ïîëîæèòåëüíîãî ýôôåêòà æäàòü íå ïðèõîäèòñÿ. Âî âñÿêîì ñëó÷àå ÿ âèäåë ñ äåñÿòîê ïîäîáíûõ áîëüíûõ, âûíóæäåííûõ ìåíÿòü ïîëå äåÿòåëüíîñòè.( Êñòàòè î ÷åì îíè â äàëüíåéøåì è íå æàëåëè! Ýòî î÷åíü âàæíî!!)

    Íàáëþäàëèñü âðåìåííûå óëó÷øåíèÿ ( êàê è â ýòîì ñëó÷àå), ñ äàëüíåéøèì *ðàñøèðåíèåì* ïðîöåññà.

    Êîíå÷íî ïðîáîâàòü ïñèõîòåðàïèþ íàäî, òàê æå íåîáõîäèì è ïñèõîëîã.

    Óðîâåíü íà÷àëüíèêîâ - âñåãäà ñëîæåí äëÿ ðàáîòû, îäíàêî è ìîòèâàöèÿ âåëèêà. Äëÿ íà÷àëà, èìååò ñìûñë ïðåäëîæèòü ðàáîòàòü íà êîìïüþòîðå, õîòÿ ìîæåò îêàçàòüñÿ, ÷òî è ýòî íå âûõîä è ñïàñòè÷åñêîå ñîñòîÿíèå áóäåò âûçûâàòü êëàâèàòóðà.

  12. Àâàòàð äëÿ nedug61816 Íîâè÷îê
    ñîîáùåíèé
    1
    ëåò 10 íàçàä ó ìåíÿ ïîÿâèëèñü ñèìïòîìû îïèñàííûå âàìè âûøå. Ïîñòàâèëè äèàãíîç ôîêàëüíàÿ äèñòîíèÿ - ïèñ÷èé ñïàçì. Ïðè÷èíó âîçíèêíîâåíèÿ äî ñèõ ïîð óñòàíîâèòü íå ìîãó. Ëå÷èëñÿ ó íåâðîïàòîëîãà, äåëàë èãëîóêàëûâàíèå. Ðåçóëüòàòà ïî÷òè íå áûëî. Ïîñëå èóëîóêàëûâàíèÿ ðóêà íà÷àëà äðîæàòü. Ñî âðåìåíåì ïðîøëî ñàìî ñîáîé. Íàó÷èëñÿ ïèñàòü ëåâîé ðóêîé. Îäíî âðåìÿ õîðîøèé ðåçóëüòàò äàëî ïëàâàíèå, íî êàê-òî ðàç âîäà áûëà õîëîäíàÿ è îïÿòü ïîÿâèëèñü ñïàçìû. Ðóêà ó ìåíÿ íå áîëèò, íî âîçíèêàåò ñóäîðîãà, ðó÷êó ïðîñòî íåâîçìîæíî äåðæàòü

  13. êàòåãîðèÿ: ìåäèöèíñêèå ÝÊÑÏÅÐÒÛ, ìîäåðàòîðû, êîíñóëüòàíòû Nedug.Ru :::::
    ñîîáùåíèé
    2,013
    Öèòàòà Ñîîáùåíèå îò nedug61816 Ïîñìîòðåòü ñîîáùåíèå
    ëåò 10 íàçàä ó ìåíÿ ïîÿâèëèñü ñèìïòîìû îïèñàííûå âàìè âûøå. Ïîñòàâèëè äèàãíîç ôîêàëüíàÿ äèñòîíèÿ - ïèñ÷èé ñïàçì. Ïðè÷èíó âîçíèêíîâåíèÿ äî ñèõ ïîð óñòàíîâèòü íå ìîãó. Ëå÷èëñÿ ó íåâðîïàòîëîãà, äåëàë èãëîóêàëûâàíèå. Ðåçóëüòàòà ïî÷òè íå áûëî. Ïîñëå èóëîóêàëûâàíèÿ ðóêà íà÷àëà äðîæàòü. Ñî âðåìåíåì ïðîøëî ñàìî ñîáîé. Íàó÷èëñÿ ïèñàòü ëåâîé ðóêîé. Îäíî âðåìÿ õîðîøèé ðåçóëüòàò äàëî ïëàâàíèå, íî êàê-òî ðàç âîäà áûëà õîëîäíàÿ è îïÿòü ïîÿâèëèñü ñïàçìû. Ðóêà ó ìåíÿ íå áîëèò, íî âîçíèêàåò ñóäîðîãà, ðó÷êó ïðîñòî íåâîçìîæíî äåðæàòü
    Ïðîâîäèëîñü ëè Âàì ÝÝÃ è ÌÐÒ èññëåäîâàíèå?
    Ñ óâàæåíèåì, Ñîáîëü À.À.,âðà÷-ïñèõîòåðàïåâò, ïñèõèàòð, íàðêîëîã.
    www.pobedi-problemu.ru

  14. Àâàòàð äëÿ nedug79437 Íîâè÷îê
    ñîîáùåíèé
    1
    Çäðàâñòâóéòå!Ó ìåíÿ òîæå äèàãíîç-ôîêàëüíàÿ ìûøå÷íàÿ äèñòîíèÿ â ôîðìå ïèñ÷åãî ñïàçìà.Áîëåþ áîëåå 2-õ ëåò.Ðàáîòàþ ìåäñåñòðîé ïî ìàññàæó.Ëå÷èëàñü â ÍÈÈ íåâðîëîãèè â Ìèíñêå.Ââîäèëè 200 åä.äèñïîðòà.Íè÷åãî íå ïîìîãëî.Ïèøó äâóìÿ ðóêàìè. ïðàâîé äåðæó ðó÷êó,à ëåâîé ïðèäåðæèâàþ ,÷òîá áóêâû ïîëó÷àëèñü áîëåå-ìåíåå.Ìîæåò ìîÿ ïðèñïîñîáëåííîñòü ê íåäóãó áóäåò êîìó-òî ïîëåçíîé...

  15. Àâàòàð äëÿ nedug87422 Íîâè÷îê
    ñîîáùåíèé
    1
    Äîáðûé äåíü. Ñåé÷àñ ìíå 25 ëåò, óæå 5 ëåò ñòðàäàþ îò ïèñ÷åãî ñïàçìà. Ëå÷èëàñü èãëîðåôëåêñîòåðàïèåé, õîäèëà íà ìàññàæ. Ýôôåêò áûë ñîâñåì íåáîëüøîé. Íè÷åãî áîëüøåãî â ìî¸ì ãîðîäå ïðåäëîæèòü íå ìîãóò. Æèâó â Áåëàðóñè. ß î÷åíü õî÷ó âûëå÷èòüñÿ. Ïîäñêàæèòå, ïîæàëóéñòà, êóäà è ê êîìó ÿ ìîãëà áû îáðàòèòüñÿ â Ìèíñêå ñ äàííûì çàáîëåâàíèåì?

Êëèíèêà ñòîìàòîëîãèè è êîñìåòîëîãèè â Ìîñêâå

Ìåòêè ýòîé òåìû

Âàøè ïðàâà

  • Âû ìîæåòå ñîçäàâàòü íîâûå òåìû
  • Âû ìîæåòå îòâå÷àòü â òåìàõ
  • Âû íå ìîæåòå ïðèêðåïëÿòü âëîæåíèÿ
  • Âû íå ìîæåòå ðåäàêòèðîâàòü ñâîè ñîîáùåíèÿ
  •